Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer

International Journal of Urology

Volumn 15, Issue 4, 2008, Pages 314-318

  Muramaki, Mototsugu ^a   Miyake, Hideaki ^a,c   Kurahashi, Toshifumi ^a   Takenaka, Atsushi ^a   Inoue, Taka Aki ^b   Fujisawa, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HYOGO CANCER CENTER   (Japan)

^c HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

Author keywords

Adjuvant chemotherapy; Concomitant carcinoma in situ; Invasive bladder cancer; Lymph node metastasis

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMA IN SITU; COMBINATION CHEMOTHERAPY; CYSTECTOMY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 41749120081     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02000.x     Document Type: Article

References (16)

1. Thurman SA, DeWeese TL. Multimodality therapy for the treatment of muscle-invasive bladder cancer. Semin. Urol. Oncol. 2000 18:313 22.
2. Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J. Clin. Oncol. 2001 19:666 75.
3. Madersbacher S, Hochreiter W, Burkhard F et al. Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J. Clin. Oncol. 2003 21:690 6.
4. Bellmunt J, Albiol S. Chemotherapy for metastatic or unresectable bladder cancer. Semin. Oncol. 2007 34:135 44.
5. Skinner DG, Daniels JR, Russell CA et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J. Urol. 1991 145:459 64.
6. Studer UE, Bacchi M, Biedermann C et al. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial. J. Urol. 1994 152:81 4.
7. Stockle M, Meyenburg W, Wellek S et al. Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J. Urol. 1992 148:302 6.
8. Sternberg CN, Donat SM, Bellmunt J et al. Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. Urology 2007 69:62 79.
9. Sternberg CN, Yagoda A, Scher HI et al. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J. Urol. 1985 133:403 7.
10. Gohji K, Ono Y, Takenaka A et al. Long-term follow-up results of a Pilot Phase II study of multidrug chemotherapy (MVP-CAB) in patients with advanced urothelial cancer. Jpn. J. Clin. Oncol. 1999 29:204 8.
11. Miyake H, Sakai I, Harada K, Hara I, Eto H. Long-term outcome of adjuvant chemotherapy with MVP-CAB regimen (methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin) for locally advanced bladder cancer. Urooncology 2004 4:151 6.
12. Loehrer PJ Einhorn LH, Elson PJ et al. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J. Clin. Oncol. 1992 10:1066 73.
13. Gschwend JE, Fair WR, Vieweg J. Radical cystectomy for invasive bladder cancer: contemporary results and remaining controversies. Eur. Urol. 2000 38:121 30.
14. Miyake H, Gohji K, Hara I et al. Long-term results of neoadjuvant treatment with M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for locally invasive transitional cell carcinoma of the urothelium. Int. J. Clin. Oncol. 1999 4:32 5.
15. Rogers CG, Palapattu GS, Shariat SF et al. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. J. Urol. 2006 175:2048 53.
16. Schumacher MC, Scholz M, Weise ES, Fleischmann A, Thalmann GN, Studer UE. Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder? J. Urol. 2006 176:2409 13.